Ahmed M. Khalaf

Ahmed M. Khalaf

Auto-generated profile, based on publicly available information

Ahmed M. Khalaf

Departments of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Journal of Hepatocellular Carcinoma
Verified
Journal Article
Open access
PDF file
AKAhmed M Khalaf
Ahmed M Khalaf
DFDavid Fuentes
David Fuentes
AMAli I Morshid
Ali I Morshid
MBMata R Burke
Mata R Burke
AKAhmed O Kaseb
Ahmed O Kaseb
KEKhaled M. Elsayes
Khaled M. Elsayes
Hepatocellular carcinoma (HCC) is one of the most common primary hepatic malignancies and one of the fastest-growing causes of cancer-related mortality in the United States. The molecular basis of HCC carcinogenesis has not been clearly identified. Among the molecular signaling pathways implicated in the pathogenesis of HCC, the Wnt/β-catenin signaling pathway is one of the most frequently activated. A great effort is under way to clearly understand the role of this pathway in the pathogenesis of HCC and its role in the transition from chronic liver diseases, including viral hepatitis, to hepatocellular adenomas (HCAs) and HCCs and its targetability in novel therapies. In this article, we review the role of the β-catenin pathway in hepatocarcinogenesis and progression from chronic inflammation to HCC, the novel potential treatments targeting the pathway and its prognostic role in HCC patients, as well as the imaging features of HCC and their association with aberrant activation of the pathway.

1 September 2019 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
AMAli Morshid
Ali Morshid
KEKhaled M. Elsayes
Khaled M. Elsayes
AKAhmed M. Khalaf
Ahmed M. Khalaf
MEMohab Elmohr
Mohab Elmohr
JYJustin Yu
Justin Yu
DFDavid Fuentes
David Fuentes
Prediction of hepatocellular carcinoma response to transcatheter arterial chemoembolization (TACE) using quantitative imaging and clinical measurements of pretreatment lesions is a potentially usef... Purpose To evaluate a fully automated machine learning algorithm that uses pretherapeutic quantitative CT image features and clinical factors to predict hepatocellular carcinoma (HCC) response to t...

18 January 2023 in Scientific Data
Verified
Journal Article
Open access
PDF file
AMAhmed Moawad
Ahmed Moawad
AMAli Morshid
Ali Morshid
AKAhmed M. Khalaf
Ahmed M. Khalaf
MEMohab Elmohr
Mohab Elmohr
JHJohn D. Hazle
John D. Hazle
KEKhaled M. Elsayes
Khaled M. Elsayes
Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm, and its incidence has doubled over the past two decades owing to increasing risk factors. Despite surveillance, most HCC cases are diagnosed at advanced stages and can only be treated using transarterial chemo-embolization (TACE) or systemic therapy. TACE failure may occur with incidence reaching up to 60% of cases, leaving patients with a financial and emotional burden. Radiomics has emerged as a new tool capable of predicting tumor response to TACE from pre-procedural computed tomography (CT) studies. This data report defines the HCC-TACE data collection of confirmed HCC patients who underwent TACE and have pre- and post-procedure CT imaging studies and available treatment outcomes (time-to-progression and overall survival). Clinically curated segmentation of pre-procedural CT studies was done for the purpose of algorithm training for prediction and automatic liver tumor segmentation.

4 May 2017 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
CJCorey T. Jensen
Corey T. Jensen
ACAntoun Chahin
Antoun Chahin
VAVeral D. Amin
Veral D. Amin
AKAhmed M. Khalaf
Ahmed M. Khalaf
KEKhaled M. Elsayes
Khaled M. Elsayes
DBDeepak G. Bedi
Deepak G. Bedi
Objectives: To determine whether the qualitative sonographic appearance of slow deep venous flow in the lower extremities correlates with quantitative slow flow and an increased risk of deep venous thrombosis (DVT) in oncology patients.Methods: In this Institutional Review Board–approved retrospective study, we reviewed lower extremity venous Doppler sonographic examinations of 975 consecutive patients: 482 with slow flow and 493 with normal flow. The subjective slow venous flow and absence of initial DVT were confirmed by 2 radiologists. Peak velocities were recorded at 3 levels. Each patient was followed for DVT development. The associations between DVT and the presence of slow venous flow were examined by the Fisher exact test; a 2‐sample t test was used for peak velocity and DVT group comparisons. The optimal cutoff peak velocity for correlation with the radiologists' perceived slow flow was determined by the Youden index.Results: Deep venous thrombosis development in the slow‐flow group (21 of 482 [4.36%]) was almost doubled compared with patients who had normal flow (11 of 493 [2.23%]; P = .0456). Measured peak venous velocities were lower in the slow–venous flow group (P < .001). Patients with subsequent DVT did not have a significant difference in venous velocities compared with their respective patient groups. The sum of 3 venous level velocities resulted in the best cutoff for dichotomizing groups into normal versus slow venous flow.Conclusions: Qualitative slow venous flow in the lower extremities on Doppler sonography accurately correlates with quantitatively slower flow, and this preliminary evaluation suggests an associated mildly increased rate of subsequent DVT development in oncology patients.

10 March 2017 in American Journal of Case Reports
Verified
Journal Article
Open access
PDF file
AKAhmed M. Khalaf
Ahmed M. Khalaf
MHMahmoud A. Hashim
Mahmoud A. Hashim
MAMohammed Alsharabati
Mohammed Alsharabati
KFKenneth Fallon
Kenneth Fallon
JCJoel K. Cure
Joel K. Cure
ASAyman Saad
Ayman Saad
BACKGROUND:Toxoplasmosis is an uncommon but potentially fatal complication following allogeneic hematopoietic stem cell transplantation (HCT). Post-transplant toxoplasmosis is often a reactivation of prior infection and typically occurs within the fi...

7 May 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
AMAhmed W. Moawad
Ahmed W. Moawad
DFDavid Fuentes
David Fuentes
AKAhmed M. Khalaf
Ahmed M. Khalaf
KBKatherine J. Blair
Katherine J. Blair
JSJanio Szklaruk
Janio Szklaruk
KEKhaled M. Elsayes
Khaled M. Elsayes
Background: Hepatocellular carcinoma (HCC) is the most common liver malignancy and the leading cause of death in patients with cirrhosis. Various treatments for HCC are available, including transarterial chemoembolization (TACE), which is the commonest intervention performed in HCC. Radiologic tumor response following TACE is an important prognostic factor for patients with HCC. We hypothesized that, for large HCC tumors, assessment of treatment response made with automated volumetric response evaluation criteria in solid tumors (RECIST) might correlate with the assessment made with the more time- and labor-intensive unidimensional modified RECIST (mRECIST) and manual volumetric RECIST (M-vRECIST) criteria. Accordingly, we undertook this retrospective study to compare automated volumetric RECIST (A-vRECIST) with M-vRECIST and mRESIST for the assessment of large HCC tumors' responses to TACE. Methods: We selected 42 pairs of contrast-enhanced computed tomography (CT) images of large HCCs. Images were taken before and after TACE, and in each of the images, the HCC was segmented using both a manual contouring tool and a convolutional neural network. Three experienced radiologists assessed tumor response to TACE using mRECIST criteria. The intra-class correlation coefficient was used to assess inter-reader reliability in the mRECIST measurements, while the Pearson correlation coefficient was used to assess correlation between the volumetric and mRECIST measurements. Results: Volumetric tumor assessment using automated and manual segmentation tools showed good correlation with mRECIST measurements. For A-vRECIST and M-vRECIST, respectively, r = 0.597 vs. 0.622 in the baseline studies; 0.648 vs. 0.748 in the follow-up studies; and 0.774 vs. 0.766 in the response assessment (P < 0.001 for all). The A-vRECIST evaluation showed high correlation with the M-vRECIST evaluation (r = 0.967, 0.937, and 0.826 in baseline studies, follow-up studies, and response assessment, respectively, P < 0.001 for all). Conclusion: Volumetric RECIST measurements are likely to provide an early marker for TACE monitoring, and automated measurements made with a convolutional neural network may be good substitutes for manual volumetric measurements.